Compounding Chemotherapy Market: By Dose Type (Chemotherapeutic, Non-Chemotherapeutics, Others), By Compounding Type (Pharmaceutical Ingredient Alteration (PIA), Currently Unavailable Pharmaceutical Manufacturing (CUPM), Pharmaceutical Dosage Alteration (PDA), By Delivery Method (Gravimetric Automated Compounding Device (weight-based), Volumetric Automated Compounding Device (volume-based)), By Sterility (Sterile, Non-sterile), By Technology (With Robotic Arms, Without Robotic Arms), and Geography

Purchase Option

$ 4400
$ 6600
$ 8900

1. Executive Summary
2. Global Compounding Chemotherapy Market Introduction
2.1. Global Compounding Chemotherapy Market – Taxonomy
2.2. Global Compounding Chemotherapy Market –Definitions
2.2.1. By Dose Type
2.2.2. By Compounding Type
2.2.3. By Delivery Method
2.2.4. By Sterility
2.2.5. By Technology
2.2.6. By Region
3. Global Compounding Chemotherapy Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Compounding Chemotherapy Market Dynamic Factors - Impact Analysis
3.6. Global Compounding Chemotherapy Market – Competition Landscape
4. Global Compounding Chemotherapy Market Analysis, 2017-2021 and Forecast, 2022-2028
4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Opportunity Analysis
5. Global Compounding Chemotherapy Market, By Dose Type, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.1. Chemotherapeutic
5.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3. Market Opportunity Analysis
5.2. Non-Chemotherapeutics
5.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3. Market Opportunity Analysis
6. Global Compounding Chemotherapy Market, By Compounding Type, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.1. Pharmaceutical Ingredient Alteration (PIA)
6.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. Currently Unavailable Pharmaceutical Manufacturing (CUPM)
6.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
6.3. Pharmaceutical Dosage Alteration (PDA)
6.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.3.3. Market Opportunity Analysis
7. Global Compounding Chemotherapy Market, By Delivery Method, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.1. Gravimetric Automated Compounding Device (weight-based)
7.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Volumetric Automated Compounding Device (volume-based)
7.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
8. Global Compounding Chemotherapy Market Forecast, By Sterility, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
8.1. Sterile
8.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.1.3. Market Opportunity Analysis
8.2. Non-sterile
8.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.2.3. Market Opportunity Analysis
9. Global Compounding Chemotherapy Market Forecast, By End User, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
9.1. With Robotic Arms
9.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
9.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.1.3. Market Opportunity Analysis
9.2. Without Robotic Arms
9.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
9.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.2.3. Market Opportunity Analysis
10. Global Compounding Chemotherapy Market Forecast, By Region, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
10.1. North America
10.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
10.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
10.1.3. Market Opportunity Analysis
10.2. Europe
10.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
10.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
10.2.3. Market Opportunity Analysis
10.3. Asia-Pacific
10.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
10.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
10.3.3. Market Opportunity Analysis
10.4. Latin America
10.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
10.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
10.4.3. Market Opportunity Analysis
10.5. Middle East and Africa
10.5.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
10.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
10.5.3. Market Opportunity Analysis
10.6. Global Compounding Chemotherapy Market - Opportunity Analysis Index, By Dose Type, By Compounding Type, By Delivery Method, By Sterility, By Technology, and Region, 2022-2028
11. North America Compounding Chemotherapy Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
11.1. Dose Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.1.1. Chemotherapeutic
11.1.2. Non-Chemotherapeutics
11.1.3. Others
11.2. Compounding Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.2.1. Pharmaceutical Ingredient Alteration (PIA)
11.2.2. Currently Unavailable Pharmaceutical Manufacturing (CUPM)
11.2.3. Pharmaceutical Dosage Alteration (PDA)
11.3. Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.3.1. Gravimetric Automated Compounding Device (weight-based)
11.3.2. Volumetric Automated Compounding Device (volume-based)
11.4. Sterility Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.4.1. Sterile
11.4.2. Non-sterile
11.5. Technology Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.5.1. With Robotic Arms
11.5.2. Without Robotic Arms
11.6. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
11.6.1. USA
11.6.2. Canada
11.7. North America Compounding Chemotherapy Market - Opportunity Analysis Index, By Dose Type, By Compounding Type, By Delivery Method, By Sterility, By Technology, and Country, 2022-2028
11.8. North America Compounding Chemotherapy Market Dynamics – Trends
12. Europe Compounding Chemotherapy Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
12.1. Dose Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.1.1. Chemotherapeutic
12.1.2. Non-Chemotherapeutics
12.1.3. Others
12.2. Compounding Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.2.1. Pharmaceutical Ingredient Alteration (PIA)
12.2.2. Currently Unavailable Pharmaceutical Manufacturing (CUPM)
12.2.3. Pharmaceutical Dosage Alteration (PDA)
12.3. Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.3.1. Gravimetric Automated Compounding Device (weight-based)
12.3.2. Volumetric Automated Compounding Device (volume-based)
12.4. Sterility Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.4.1. Sterile
12.4.2. Non-sterile
12.5. Technology Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.5.1. With Robotic Arms
12.5.2. Without Robotic Arms
12.6. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
12.6.1. Germany
12.6.2. UK
12.6.3. France
12.6.4. Spain
12.6.5. Italy
12.6.6. Russia
12.6.7. Rest of Europe
12.7. Europe Compounding Chemotherapy Market - Opportunity Analysis Index, By Dose Type, By Compounding Type, By Delivery Method, By Sterility, By Technology, and Country, 2022-2028
12.8. Europe Compounding Chemotherapy Market Dynamics – Trends
13. Asia-Pacific Compounding Chemotherapy Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
13.1. Dose Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.1.1. Chemotherapeutic
13.1.2. Non-Chemotherapeutics
13.1.3. Others
13.2. Compounding Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.2.1. Pharmaceutical Ingredient Alteration (PIA)
13.2.2. Currently Unavailable Pharmaceutical Manufacturing (CUPM)
13.2.3. Pharmaceutical Dosage Alteration (PDA)
13.3. Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.3.1. Gravimetric Automated Compounding Device (weight-based)
13.3.2. Volumetric Automated Compounding Device (volume-based)
13.4. Sterility Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.4.1. Sterile
13.4.2. Non-sterile
13.5. Technology Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.5.1. With Robotic Arms
13.5.2. Without Robotic Arms
13.6. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
13.6.1. China
13.6.2. India
13.6.3. Japan
13.6.4. ASEAN
13.6.5. Australia & New Zealand
13.6.6. Rest of Asia-Pacific
13.7. Asia-Pacific Compounding Chemotherapy Market - Opportunity Analysis Index, By Dose Type, By Compounding Type, By Delivery Method, By Sterility, By Technology, and Country, 2022-2028
13.8. Asia-Pacific Compounding Chemotherapy Market Dynamics – Trends
14. Latin America Compounding Chemotherapy Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
14.1. Dose Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
14.1.1. Chemotherapeutic
14.1.2. Non-Chemotherapeutics
14.1.3. Others
14.2. Compounding Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
14.2.1. Pharmaceutical Ingredient Alteration (PIA)
14.2.2. Currently Unavailable Pharmaceutical Manufacturing (CUPM)
14.2.3. Pharmaceutical Dosage Alteration (PDA)
14.3. Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.3.1. Gravimetric Automated Compounding Device (weight-based)
14.3.2. Volumetric Automated Compounding Device (volume-based)
14.4. Sterility Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.4.1. Sterile
14.4.2. Non-sterile
14.5. Technology Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.5.1. With Robotic Arms
14.5.2. Without Robotic Arms
14.6. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
14.6.1. Brazil
14.6.2. Mexico
14.6.3. Rest of Latin America
14.7. Latin America Compounding Chemotherapy Market - Opportunity Analysis Index, By Dose Type, By Compounding Type, By Delivery Method, By Sterility, By Technology, and Country, 2022-2028
14.8. Latin America Compounding Chemotherapy Market Dynamics – Trends
15. Middle East and Africa Compounding Chemotherapy Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
15.1. Dose Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
15.1.1. Chemotherapeutic
15.1.2. Non-Chemotherapeutics
15.1.3. Others
15.2. Compounding Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
15.2.1. Pharmaceutical Ingredient Alteration (PIA)
15.2.2. Currently Unavailable Pharmaceutical Manufacturing (CUPM)
15.2.3. Pharmaceutical Dosage Alteration (PDA)
15.3. Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
15.3.1. Gravimetric Automated Compounding Device (weight-based)
15.3.2. Volumetric Automated Compounding Device (volume-based)
15.4. Sterility Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
15.4.1. Sterile
15.4.2. Non-sterile
15.5. Technology Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
15.5.1. With Robotic Arms
15.5.2. Without Robotic Arms
15.6. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
15.6.1. Gulf Cooperation Council (GCC) Countries
15.6.2. South Africa
15.6.3. Rest of MEA
15.7. MEA Compounding Chemotherapy Market - Opportunity Analysis Index By Dose Type, By Compounding Type, By Delivery Method, By Sterility, By Technology, and Country, 2022-2028
15.8. MEA Compounding Chemotherapy Market Dynamics – Trends
16. Competition Landscape 
16.1. Strategic Dashboard of Top Market Players
16.2. Company Profiles (Introduction, Financial Analysis, Key Dose Types, Key Developments, Strategies, and SWOT Analysis)
16.2.1. Pharma B.V.
16.2.2. Arxium, Inc.
16.2.3. Baxter International Inc.
16.2.4. B. Braun Melsungen AG
16.2.5. Comecer S.P.A.
16.2.6. Dedalus S.P.A.
16.2.7. Equashield, LLC.
16.2.8. Grifols
16.2.9. Icon Group
16.2.10. Loccioni Group.
16.2.11. Miller Pharmacy Inc.
16.2.12. Omnicell, Inc.
16.2.13. Pfizer, Inc.
17. Research Methodology
18. Key Assumptions and Acronyms

Key Features of the Reports

  • The report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario

Frequently Asked Questions

2021 is the base year and 2028 is the forecast year.

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.

 
  • Pharma B.V.
  • Arxium, Inc.
  • Baxter International Inc.
  1. Braun Melsungen AG
  • Comecer S.P.A.
  • Dedalus S.P.A.
  • Equashield, LLC.
  • Grifols
  • Icon Group
  • Loccioni Group.
  • Miller Pharmacy Inc.
  • Omnicell, Inc.
  •  Pfizer, Inc.

Adjacent Markets

Eosinophilia Market
Dyspepsia Market
Disseminated Intravascular Coagulation Market
Alpha Thalassemia Market
Allergic Rhinitis Market
Histamine Analogs Market